Radiolabeling Approaches of Nanoparticles with (99m) Tc
Overview
Authors
Affiliations
Nanomedicine applications have recently gathered great attention in terms of their revolutionary properties and multivalency. Nanoparticles (NPs) have proven useful owing to their size, surface and kinetics advantages, as well as their ability to be functionalized with targeting, imaging and therapeutic moieties. Nuclear medicine is actively involved in nano-research innovative breakthrough efforts in multiple applications, through the radiolabeling of NP structures. There are several ways that NP-radiolabeling can be approached depending on the radionuclide that is used and the NP type. The radiolabeling of NPs with the most widely and easily available radiometal, which is (99m) Tc, is the focus of this review.
Salgueiro M, Portillo M, Tesan F, Nicoud M, Medina V, Moretton M EJNMMI Radiopharm Chem. 2024; 9(1):74.
PMID: 39470937 PMC: 11522242. DOI: 10.1186/s41181-024-00300-z.
Schorr K, Chen X, Sasaki T, Arias-Loza A, Lang J, Higuchi T ACS Pharmacol Transl Sci. 2024; 7(9):2604-2611.
PMID: 39296255 PMC: 11406700. DOI: 10.1021/acsptsci.4c00383.
Radiolabeling of bionanomaterials with technetium 99m: current state and future prospects.
Trusova V, Karnaukhov I, Zelinsky A, Borts B, Ushakov I, Sidenko L Nanomedicine (Lond). 2024; 19(17):1569-1580.
PMID: 39011593 PMC: 11321418. DOI: 10.1080/17435889.2024.2368454.
Asensio Ruiz M, Alonso Garcia A, Bravo-Ferrer Moreno M, Cebreiros-Lopez I, Noguera-Velasco J, Lozano-Perez A Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259395 PMC: 9959965. DOI: 10.3390/ph16020248.
[Tc]Technetium-Labeled Niosomes: Radiolabeling, Quality Control, and Evaluation.
Ekinci M, Caliskan E, Cakar B, Ilem-Ozdemir D, Uyanikgil Y, Cetin Uyanikgil E ACS Omega. 2023; 8(7):6279-6288.
PMID: 36844604 PMC: 9948160. DOI: 10.1021/acsomega.2c06179.